Kings Point Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Kings Point Capital Management's AMGN Position: Q1 2022 in Review
Kings Point Capital Management reduced its Amgen (AMGN) stake by 4% in Q1 2022, selling an estimated $19.8K and leaving 2,047 shares worth $495K. The position accounts for 0.04% of the portfolio, ranked #134.
Kings Point Capital Management first reported a position in AMGN in Q2 2014 and has held it in 22 quarters since. The position peaked at $5.35M in Q4 2018. 2,337 funds tracked by Wall St. Rank hold AMGN as of Q1 2022.
- Kings Point Capital Management held 2,047 shares of Amgen worth $495K as of Q1 2022.
- Kings Point Capital Management sold 86 Amgen shares in Q1 2022, an estimated $19.8K.
- Amgen made up 0.04% of Kings Point Capital Management's portfolio in Q1 2022, its #134 holding.
- Kings Point Capital Management first reported a position in Amgen in Q2 2014 and has held it in 22 quarters since.
- Kings Point Capital Management's Amgen position peaked at $5.35M in Q4 2018.
- 2,337 funds tracked by Wall St. Rank held Amgen as of Q1 2022.
Based on Kings Point Capital Management's 13F filing for Q1 2022, filed 13 May 2022.